UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 419

Sortiert nach

Digital ulcers and outcomes assessment in scleroderma

Rheumatology (Oxford, England), 2008-10, Vol.47 (suppl-5), p.v46-v47

2008

Volltextzugriff (PDF)

Minimally important difference in diffuse systemic sclerosis: results from the d-penicillamine study

Annals of the rheumatic diseases, 2006-10, Vol.65 (10), p.1325-1329

2006

Volltextzugriff (PDF)

Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis

Annals of the rheumatic diseases, 2007-12, Vol.66 (12), p.1641-1647

2007

Volltextzugriff (PDF)

Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test

Annals of the rheumatic diseases, 2007-02, Vol.66 (2), p.169-173

2007

Volltextzugriff (PDF)

Development of a provisional core set of response measures for clinical trials of systemic sclerosis

Annals of the rheumatic diseases, 2008-05, Vol.67 (5), p.703-709

2008

Volltextzugriff (PDF)

The 6-minute walk test in scleroderma—how measuring everything measures nothing

Rheumatology (Oxford, England), 2008-10, Vol.47 (suppl-5), p.v68-v69

2008

Volltextzugriff (PDF)

Junctional adhesion molecule-A is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion

Annals of the rheumatic diseases, 2010-01, Vol.69 (1), p.249-254

2010

Volltextzugriff (PDF)

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

Annals of the rheumatic diseases, 2011-01, Vol.70 (1), p.32-38

2011

Volltextzugriff (PDF)

SP0122 Pulmonary Arterial Hypertension in the Connective Tissue Diseases - The New Era of Evidence

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A28-A29

Seibold, J. R.

2013

Volltextzugriff (PDF)

Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards

Rheumatology (Oxford, England), 2015-01, Vol.54 (1), p.144-151

2015

Volltextzugriff (PDF)

Trial design: how must we move ahead?

Rheumatology (Oxford, England), 2008-10, Vol.47 (suppl-5), p.v57-v58

2008

Volltextzugriff (PDF)

Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies

Journal of rheumatology, 1993-11, Vol.20 (11), p.1892

1993

Volltextzugriff (PDF)

A path to the future in scleroderma

Rheumatology (Oxford, England), 2008-10, Vol.47 (suppl-5), p.v1-v1

2008

Volltextzugriff (PDF)

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study

Annals of internal medicine, 1994-02, Vol.120 (3), p.199

1994

Volltextzugriff (PDF)

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

Clinical pharmacology and therapeutics, 1999-03, Vol.65 (3), p.336-347

1999

Volltextzugriff (PDF)

The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1

Rheumatology (Oxford, England), 2009-07, Vol.48 (7), p.734-740

2009

Volltextzugriff (PDF)

Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial

Annals of internal medicine, 2000-06, Vol.132 (11), p.871

2000

Volltextzugriff (PDF)

Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist

Arthritis and rheumatism, 2004-12, Vol.50 (12), p.3985-3993

2004

Volltextzugriff (PDF)

Sexual activity and functioning in female scleroderma patients

Clinical and experimental rheumatology, 2009-05, Vol.27 (3 Suppl 54), p.38

2009

Volltextzugriff (PDF)

Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research Initiative

Clinical and experimental rheumatology, 2014-11, Vol.32 (6 Suppl 86), p.S

2014

Volltextzugriff (PDF)

Treatment of arthritis with topical capsaicin: a double-blind trial

Clinical therapeutics, 1991-05, Vol.13 (3), p.383

1991

Volltextzugriff (PDF)

The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis

Journal of rheumatology, 1998-01, Vol.25 (1), p.84

1998

Volltextzugriff (PDF)

Randomized, prospective, placebo‐controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis

Arthritis and rheumatism, 2010-07, Vol.62 (7), p.2101-2108

2010

Volltextzugriff (PDF)

OP0036 An Evidence-Based Tool for Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis: The Detect Study

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A60-A61

2013

Volltextzugriff (PDF)

FRI0397 Baseline characteristics of systemic sclerosis patients with borderline mean pulmonary artery pressure: post-hoc analysis from the detect study

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A507-A508

2013

Volltextzugriff (PDF)

1 – 25 von 419

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(353)
Mit Volltextzugriff
(331)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(271)
Life Sciences & Biomedicine
(247)
Humans
(230)
Female
(153)
Male
(139)
Biological And Medical Sciences
(124)
Medical Sciences
(120)
Rheumatology
(118)
Adult
(117)
Middle Aged
(109)
Aged
(53)
Animals
(41)
Systemic Sclerosis
(38)
Treatment Outcome
(38)
Scleroderma, Systemic - Complications
(37)
Scleroderma
(36)
Adolescent
(34)
Pharmacology. Drug Treatments
(34)
Asthma
(30)
Diseases Of The Osteoarticular System
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Digital ulcers and outcomes assessment in scleroderma

Minimally important difference in diffuse systemic sclerosis: results from the d-penicillamine study

Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis

Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test

Development of a provisional core set of response measures for clinical trials of systemic sclerosis

The 6-minute walk test in scleroderma—how measuring everything measures nothing

Junctional adhesion molecule-A is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

SP0122 Pulmonary Arterial Hypertension in the Connective Tissue Diseases - The New Era of Evidence

Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards

Trial design: how must we move ahead?

Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies

A path to the future in scleroderma

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1

Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial

Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist

Sexual activity and functioning in female scleroderma patients

Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research Initiative

Treatment of arthritis with topical capsaicin: a double-blind trial

The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis

Randomized, prospective, placebo‐controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis

OP0036 An Evidence-Based Tool for Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis: The Detect Study

FRI0397 Baseline characteristics of systemic sclerosis patients with borderline mean pulmonary artery pressure: post-hoc analysis from the detect study

Suchergebnisse filtern